Blog
RSS FeedPosted by Michael Wonder on 27 Oct 2025
Flaws in the FDA’s new priority voucher program
25 October 2025 - A new FDA program is being promoted as a tool to facilitate the development and approval of ...
Posted by Michael Wonder on 17 Oct 2025
Merck announces unprecedented agreement with US Government to expand access to IVF therapies
16 October 2025 - Merck announced today that EMD Serono, the healthcare business of Merck in the US and Canada, ...
Posted by Michael Wonder on 10 Oct 2025
AstraZeneca announces historic agreement with US Government to lower the cost of medicines for American patients
10 October 2025 - AstraZeneca today announces a historic agreement with President Donald J. Trump’s administration to lower the cost ...
Posted by Michael Wonder on 09 Oct 2025
Donald Trump’s cure for drug prices is worse than the disease
2 October 2025 - Few things infuriate Americans as much as drug prices. Republicans and Democrats alike agree that poorly patients ...
Posted by Michael Wonder on 05 Oct 2025
Why Pfizer’s Trump deal is good news for all of big pharma
2 October 2025 - The company’s accord with the president clears a cloud over the whole sector. ...
Posted by Michael Wonder on 01 Oct 2025
White House unveils ‘TrumpRx’ drug buying site and a Pfizer pricing deal
30 September 2025 - The company says it gains a three year grace period to exempt it from national-security-related tariffs. ...
Posted by Michael Wonder on 28 Sep 2025
Donald Trump is waging war on sky-high drug prices. Can he win?
28 September 2025 - Big Pharma has a big headache: Donald Trump. Lately drugmakers have had to contend with the ...
Posted by Michael Wonder on 23 Sep 2025
FDA takes action to make a treatment available for autism symptoms
22 September 2025 - The US FDA today initiated the approval of leucovorin calcium tablets for patients with cerebral folate ...
Posted by Michael Wonder on 20 Sep 2025
A new era of dementia treatment is coming. We are not ready.
19 September 2025 - Inequality in accessing new drugs, the high cost of treatment, and underprepared hospital systems: these obstacles to ...
Posted by Michael Wonder on 09 Sep 2025
Revisiting the FDA’s accelerated approval pathway
8 September 2025 - After aducanumab’s accelerated approval for Alzheimer's disease, and prompted by long standing concerns regarding the accelerated approval pathway ...
Posted by Michael Wonder on 29 Aug 2025
UK Government, pharma industry fail to agree on medicines payment scheme
28 August 2025 - Negotiations between the UK Government and the pharmaceutical industry have ended without an agreement on changes ...
Posted by Michael Wonder on 11 Aug 2025
Trump’s trade war is not the only threat to cheap PBS medicines
10 August 2025 - Australia’s health system is rightly celebrated for its universal access and cost effectiveness, but its outdated assessment ...
Posted by Michael Wonder on 10 Aug 2025
America’s drug regulator is in turmoil
10 August 2025 - The already fraught oversight of rare disease treatments is becoming politicised. ...
Posted by Michael Wonder on 09 Aug 2025
Labor ‘very concerned’ by Trump pharma threat
7 August 2025 - The Albanese Government says it is “very concerned” after Donald Trump’s latest tariff threat on a key ...
Posted by Michael Wonder on 09 Aug 2025
Labor vows to ‘fight’ as Trump threatens pharma tariffs
8 August 2025 - The Albanese government is vowing to “fight for the PBS” as Donald Trump tries to strong-arm ...